1 recruiting, 1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow ClonoSeq Assay: new trials by email Literature Review of ClonoSeq Assay trials Research Report on ClonoSeq Assay
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma Obinutuzumab, Glofitamab, Pirtobrutinib - Mantle Cell Lymphoma | Phase 2 | Recruiting | University of California, San Francisco | 30 | 2024-06-11 | 2026-10-01 |
| The clonoSEQ® Watch Registry clonoSEQ Assay - Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia | Terminated | Adaptive Biotechnologies | 465 | 2020-10-13 | 2024-08-01 |
Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Neoplasm, Residual (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Adaptive Biotechnologies (1) · University of California, San Francisco (1)
United States (2)
Heidi Simmons, PhD (1) · Madhav Seshadri, MD (1)